Página 2 - Melhores Cancro da nasofaringe médicos - TOP-58 médicos

O Prof. Köstler é um oncologista médico de destaque na Wiener Privatklinik em Viena, especializado em terapias-alvo avançadas e imunoterapia.

• Mais de 20 anos de experiência como oncologista e internista
• Focar em neoplasias mamárias e ginecológicas
• Professor Associado na Universidade Médica de Viena
• Publicar pesquisas sobre desenvolvimento de biomarcadores e biologia tumoral
• Especialista na elaboração de planos de terapia sistêmica personalizada contra o cancro

Mais de 1.100 tratamentos de câncer realizados – O Dr. Ozadli é especialista em câncer de nasofaringe nos Hospitais Valued Med Hub como Professor Assistente.

• 21 anos de experiência em oncologia médica
• Formado no Hospital de Treinamento e Pesquisa em Oncologia de Ancara
• Especialista em cancros do pulmão, esófago, gástrico e da mama
• Investigador ativo com publicações em oncologia

O Dr. Fox lidera um centro de oncologia certificado em Solingen, especializado em cancros de cabeça e pescoço, incluindo cancro nasofaríngeo.

• Mais de 15 anos de experiência em hematologia e oncologia
• Especialista em diagnóstico molecular e terapias alvo
• Pesquisar ativamente novos tratamentos para doenças hemato-oncológicas
• Membro da American Association for Cancer Research

O Professor Keil é especialista em radiologia diagnóstica e intervencionista, aplicando técnicas avançadas de imagem, como ressonância magnética e tomografia computadorizada, no Hospital Académico de Solingen.

• Graduado com honras pela Universidade Julius-Maximilian de Würzburg
• Aprofundamento de competências sob a orientação do renomado Professor Rolf W. Günther
• Médico líder desde 2010 em Radiologia Diagnóstica e Intervencionista
• Especializar-se em exames de imagem transversais e serviços de radiologia intervencionista

Mais de 1.100 procedimentos oncológicos realizados – A Prof.ª Elke Jaeger é uma das principais oncologistas da Alemanha, de acordo com a classificação da Focus.

• Chefe de Oncologia e Hematologia da Clínica Nordwest
• Mais de 35 anos de experiência em oncologia
• Membro do comité de peritos da Organização Europeia para a Investigação e Tratamento do Cancro (EORTC)
• Especializada no tratamento de sarcomas

O Dr. Yildiz publicou mais de 17 artigos de pesquisa sobre tumores neuroendócrinos e casos raros de cancro, com foco no cancro da nasofaringe no Hospital Universitário Medipol Mega.

• Especializar-se em tumores neuroendócrinos e apresentações raras de cancro
• Publicar na Medical Oncology e noutras revistas revistas por pares
• Diagnosticar e tratar síndromes paraneoplásicas complexas
• Trabalhar num hospital universitário de referência com instalações oncológicas avançadas

A Dra. Orit Gutfeld é uma oncologista especializada em cancros otorrinolaringológicos (ENT), com mais de 30 anos de experiência clínica.

• Realizar milhares de cirurgias para tumores de cabeça e pescoço
• Especializar-se em técnicas minimamente invasivas, como cirurgia endoscópica
• Utilizar radiocirurgia avançada, incluindo o tratamento com Gamma Knife
• Dirigir a Divisão de Oncologia do Instituto de Radioterapia no Ichilov Medical Center
• Participar em investigações científicas e ensaios clínicos no Ichilov

O Professor Dan Fliss é um oncologista experiente, especialista em cancro da nasofaringe no Sourasky Medical Center (Ichilov).

• Especializar-se no tratamento de casos complexos de cancro da nasofaringe
• Ser afiliado a um dos principais centros médicos de Israel
• Deter o título de Professor em oncologia

O Prof. Associado Nail Paksoy é especializado em cancro da nasofaringe no Hospital Medipol Bahçelievler, contando com uma vasta experiência em oncologia.

• Certificação em oncologia médica pela ESMO
• Formação especializada no Instituto de Oncologia da Universidade de Istambul
• Participação em ensaios clínicos internacionais para tratamentos oncológicos avançados
• Publicação de investigação sobre vários temas de oncologia em revistas com revisão por pares

Especialista em oncologia médica com ampla formação na Universidade Akdeniz – uma das principais faculdades de medicina da Turquia.

• Certificado em oncologia médica desde 2018
• Mais de 15 anos de experiência em medicina interna e oncologia
• Experiência em diversos hospitais universitários, incluindo o Hospital Universitário Akdeniz
• Membro da Associação Turca de Oncologia Médica

O Dr. Ozden traz mais de uma década de experiência especializada em oncologia médica para casos de cancro da nasofaringe. Formou-se na prestigiada Faculdade de Medicina Cerrahpaşa da Universidade de Istambul.

• Concluir a subespecialidade de oncologia médica na Universidade de Kocaeli
• Praticar medicina interna e oncologia desde 2004
• Formação médica em língua inglesa
• Trabalhar no Hospital VM Medical Park Pendik

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Mais de 30 anos de especialização em viroterapia – A Dra. Jaunalksne chefia o Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins.

• Graduar-se no Instituto Médico de Riga
• Realizar internato em Medicina Interna
• Chefiar o Centro de Imunologia Clínica

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.